Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

SJL mice exposed to cuprizone intoxication reveal strain and gender pattern differences in demyelination.

Taylor LC, Gilmore W, Matsushima GK.

Brain Pathol. 2009 Jul;19(3):467-79. doi: 10.1111/j.1750-3639.2008.00230.x. Epub 2008 Oct 21.

PMID:
19016742
2.

Regional differences between grey and white matter in cuprizone induced demyelination.

Gudi V, Moharregh-Khiabani D, Skripuletz T, Koutsoudaki PN, Kotsiari A, Skuljec J, Trebst C, Stangel M.

Brain Res. 2009 Aug 4;1283:127-38. doi: 10.1016/j.brainres.2009.06.005. Epub 2009 Jun 12.

PMID:
19524552
3.

Cuprizone induces similar demyelination in male and female C57BL/6 mice and results in disruption of the estrous cycle.

Taylor LC, Gilmore W, Ting JP, Matsushima GK.

J Neurosci Res. 2010 Feb 1;88(2):391-402. doi: 10.1002/jnr.22215.

PMID:
19746424
4.

Insulin-like growth factor-1 inhibits mature oligodendrocyte apoptosis during primary demyelination.

Mason JL, Ye P, Suzuki K, D'Ercole AJ, Matsushima GK.

J Neurosci. 2000 Aug 1;20(15):5703-8.

5.

Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.

Acs P, Komoly S.

Ideggyogy Sz. 2012 Jul 30;65(7-8):266-70.

PMID:
23074847
6.

Demyelination of the hippocampus is prominent in the cuprizone model.

Koutsoudaki PN, Skripuletz T, Gudi V, Moharregh-Khiabani D, Hildebrandt H, Trebst C, Stangel M.

Neurosci Lett. 2009 Feb 13;451(1):83-8. doi: 10.1016/j.neulet.2008.11.058. Epub 2008 Dec 3.

PMID:
19084049
7.

Abbreviated exposure to cuprizone is sufficient to induce demyelination and oligodendrocyte loss.

Doan V, Kleindienst AM, McMahon EJ, Long BR, Matsushima GK, Taylor LC.

J Neurosci Res. 2013 Mar;91(3):363-73. doi: 10.1002/jnr.23174. Epub 2012 Dec 26.

PMID:
23280518
8.

Microglial Hv1 proton channel promotes cuprizone-induced demyelination through oxidative damage.

Liu J, Tian D, Murugan M, Eyo UB, Dreyfus CF, Wang W, Wu LJ.

J Neurochem. 2015 Oct;135(2):347-56. doi: 10.1111/jnc.13242. Epub 2015 Aug 11.

9.

Cuprizone effect on myelination, astrogliosis and microglia attraction in the mouse basal ganglia.

Pott F, Gingele S, Clarner T, Dang J, Baumgartner W, Beyer C, Kipp M.

Brain Res. 2009 Dec 11;1305:137-49. doi: 10.1016/j.brainres.2009.09.084. Epub 2009 Sep 30.

PMID:
19799876
10.

Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.

Acs P, Selak MA, Komoly S, Kalman B.

J Neuroimmunol. 2013 Sep 15;262(1-2):128-31. doi: 10.1016/j.jneuroim.2013.06.012. Epub 2013 Jul 26.

PMID:
23890807
11.

Experimental demyelination caused by primary oligodendrocyte dystrophy. Regional distribution of the lesions in the nervous system of mice [corrected].

Komoly S.

Ideggyogy Sz. 2005 Jan 20;58(1-2):40-3. Erratum in: Ideggyogy Sz. 2005 Mar 20;58(3-4):132.

PMID:
15884397
12.

Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

Vana AC, Flint NC, Harwood NE, Le TQ, Fruttiger M, Armstrong RC.

J Neuropathol Exp Neurol. 2007 Nov;66(11):975-88.

13.

Regional heterogeneity of cuprizone-induced demyelination: topographical aspects of the midline of the corpus callosum.

Schmidt T, Awad H, Slowik A, Beyer C, Kipp M, Clarner T.

J Mol Neurosci. 2013 Jan;49(1):80-8. doi: 10.1007/s12031-012-9896-0. Epub 2012 Oct 5.

PMID:
23054589
14.

Microglial/macrophage accumulation during cuprizone-induced demyelination in C57BL/6 mice.

Hiremath MM, Saito Y, Knapp GW, Ting JP, Suzuki K, Matsushima GK.

J Neuroimmunol. 1998 Dec 1;92(1-2):38-49.

PMID:
9916878
15.

Minocycline reduces remyelination by suppressing ciliary neurotrophic factor expression after cuprizone-induced demyelination.

Tanaka T, Murakami K, Bando Y, Yoshida S.

J Neurochem. 2013 Oct;127(2):259-70. doi: 10.1111/jnc.12289. Epub 2013 May 20.

16.

Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.

Azami Tameh A, Clarner T, Beyer C, Atlasi MA, Hassanzadeh G, Naderian H.

Ann Anat. 2013 Oct;195(5):415-23. doi: 10.1016/j.aanat.2013.03.004. Epub 2013 Apr 28.

PMID:
23711509
17.

The hippocampal fimbria of cuprizone-treated animals as a structure for studying neuroprotection in multiple sclerosis.

Kipp M, Norkus A, Krauspe B, Clarner T, Berger K, van der Valk P, Amor S, Beyer C.

Inflamm Res. 2011 Aug;60(8):723-6. doi: 10.1007/s00011-011-0339-0. Epub 2011 Apr 24.

18.

17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss.

Taylor LC, Puranam K, Gilmore W, Ting JP, Matsushima GK.

Neurobiol Dis. 2010 Aug;39(2):127-37. doi: 10.1016/j.nbd.2010.03.016. Epub 2010 Mar 27.

19.

Astrogliosis during acute and chronic cuprizone demyelination and implications for remyelination.

Hibbits N, Yoshino J, Le TQ, Armstrong RC.

ASN Neuro. 2012 Oct 30;4(6):393-408. doi: 10.1042/AN20120062.

20.

Galectin-3 controls the response of microglial cells to limit cuprizone-induced demyelination.

Hoyos HC, Rinaldi M, Mendez-Huergo SP, Marder M, Rabinovich GA, Pasquini JM, Pasquini LA.

Neurobiol Dis. 2014 Feb;62:441-55. doi: 10.1016/j.nbd.2013.10.023. Epub 2013 Oct 31.

PMID:
24184798
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk